Advertisement

Multivitamin, Multimineral Users Self-Report Better Health

0

No differences seen in history of 10 chronic diseases, current health conditions, severity of psychological distress, rates of needing help with daily activities

ACS: Antibiotics Noninferior to Appendectomy for Appendicitis

Tool Could Optimize Antibiotic Prescribing for UTI

0

Authors say decision support tool could help reduce antibiotic resistance by cutting use of broad-spectrum antibiotics

COVID-19 Infection Higher Among Support Staff Than Doctors, Nurses

0

Black and Latino workers have twice the odds of a positive virus or antibody test

Heart Failure History Linked to Adverse Outcomes in COVID-19

AHA: CVD Risk Often Unaddressed for Transgender Population

0

Of those receiving gender-affirming hormone therapy, many have CV risk factors and are not receiving appropriate therapies

Influenza Vaccination May Have Protective Effect on COVID-19

AHA: Young Adults With CVD Have Low Flu Vaccination Rates

0

Prevalence of flu vaccination lower among adults aged 18 to 34, 35 to 44 years with versus without history of MI

HealthDay Reports: Nearly Half of Coronavirus Infections May Be Asymptomatic

Antibody Treatment Approved for Emergency Use Against Early COVID-19

0

Treatment approved for people newly infected with COVID-19 who are at high risk for progressing to severe disease

11/9 12AM Why 20% of Parents Are Wary of Vaccinating Their Kids

About One in Five Children Have Vaccine-Hesitant Parent

0

Influenza vaccine coverage 26 percent lower for children of parents reported to be hesitant about childhood shots

AstraZeneca Hopes to Have COVID-19 Vaccine Ready by Year's End

Pfizer COVID-19 Vaccine Reaches 90 Percent Effectiveness in Early Analysis

0

Vaccine requires two doses, given three weeks apart

Paran un ensayo de un medicamento de anticuerpos contra la COVID-19 por falta de efectividad

New Cancer Drug Approvals Linked to Drop in Mortality

0

New cancer drugs approved between 2000 and 2016 associated with 1,291,769 fewer related deaths in the U.S.

Cabotegravir Injection Can Protect Women From HIV for Two Months

0

Experimental drug found to be 89 percent more effective at preventing HIV infection than Truvada pills